<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d169">
    <sentence id="DDI-DrugBank.d169.s0" text="Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID  (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is not likely to cause or be subject to P450-based metabolic drug interactions in man.">
        <entity charOffset="81-88" id="DDI-DrugBank.d169.s0.e0" text="REVLIMID" type="brand"/>
        <entity charOffset="92-103" id="DDI-DrugBank.d169.s0.e1" text="lenalidomide" type="drug"/>
        <entity charOffset="200-211" id="DDI-DrugBank.d169.s0.e2" text="lenalidomide" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s0.e0" e2="DDI-DrugBank.d169.s0.e1" id="DDI-DrugBank.d169.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s0.e0" e2="DDI-DrugBank.d169.s0.e2" id="DDI-DrugBank.d169.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s0.e1" e2="DDI-DrugBank.d169.s0.e2" id="DDI-DrugBank.d169.s0.p2"/>
    <negationtags>Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; likely to cause or be subject to P450-based metabolic drug interactions in man. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d169.s1" text="Co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of R- and S- warfarin.">
        <entity charOffset="48-59" id="DDI-DrugBank.d169.s1.e0" text="lenalidomide" type="drug"/>
        <entity charOffset="114-115;124-131" id="DDI-DrugBank.d169.s1.e1" text="R- warfarin" type="drug"/>
        <entity charOffset="121-131" id="DDI-DrugBank.d169.s1.e2" text="S- warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s1.e0" e2="DDI-DrugBank.d169.s1.e1" id="DDI-DrugBank.d169.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s1.e0" e2="DDI-DrugBank.d169.s1.e2" id="DDI-DrugBank.d169.s1.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s1.e1" e2="DDI-DrugBank.d169.s1.e2" id="DDI-DrugBank.d169.s1.p2"/>
    <negationtags>Co-administration of multiple doses of 10 mg of lenalidomide had &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on the single dose pharmacokinetics of R- and S- warfarin. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d169.s2" text="Co-administration of single 25-mg dose warfarin had no effect on the pharmacokinetics of total lenalidomide.">
        <entity charOffset="39-46" id="DDI-DrugBank.d169.s2.e0" text="warfarin" type="drug"/>
        <entity charOffset="95-106" id="DDI-DrugBank.d169.s2.e1" text="lenalidomide" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s2.e0" e2="DDI-DrugBank.d169.s2.e1" id="DDI-DrugBank.d169.s2.p0"/>
    <negationtags>Co-administration of single 25-mg dose warfarin had &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on the pharmacokinetics of total lenalidomide. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d169.s3" text="Expected changes in laboratory assessments of PT and INR were observed after warfarin administration, but these changes were not affected by concomitant lenalidomide administration.">
        <entity charOffset="77-84" id="DDI-DrugBank.d169.s3.e0" text="warfarin" type="drug"/>
        <entity charOffset="153-164" id="DDI-DrugBank.d169.s3.e1" text="lenalidomide" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d169.s3.e0" e2="DDI-DrugBank.d169.s3.e1" id="DDI-DrugBank.d169.s3.p0"/>
    <negationtags>Expected changes in laboratory assessments of PT and INR were observed after warfarin administration, but these changes were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by concomitant lenalidomide administration. &lt;/scope&gt;</negationtags></sentence>
</document>